You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 11,052,161


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,052,161 protect, and when does it expire?

Patent 11,052,161 protects XENOVIEW and is included in one NDA.

This patent has six patent family members in six countries.

Summary for Patent: 11,052,161
Title:Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices
Abstract:Systems, methods and related devices used to produce and collect polarized noble gas to inhibit, suppress, detect or filter alkali metal nanoclusters to preserve or increase a polarization level thereof. The systems can include a pre-sat chamber that has an Area Ratio between 20 and 500.
Inventor(s):Freeman Matthew S., Driehuys Bastiaan
Assignee:Duke University
Application Number:US16113607
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors with exclusive rights to their innovations. The United States Patent and Trademark Office (USPTO) is responsible for granting these patents, and understanding the scope and claims of a patent is essential for both inventors and businesses. This article will delve into the intricacies of patent claims, the patent landscape, and how these elements impact innovation and market competition.

What is a Patent?

A patent is a grant of exclusive rights to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. According to the Patent Act of 1790, an invention must be "sufficiently useful and important" to be patentable[4].

The Importance of Patent Claims

Patent claims are the heart of a patent application, defining the scope of the invention and what is protected by the patent. Claims must be clear, concise, and supported by the patent's description. The scope of a patent is often debated, with metrics such as independent claim length and independent claim count used to measure patent breadth[3].

Independent Claim Length and Count

Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. This suggests that the clarity and specificity of claims are critical in determining the patent's validity and scope[3].

The Patent Landscape in the United States

The USPTO awards thousands of patents annually, with a significant portion going to businesses. In 2018, the USPTO granted 309,000 utility patents, nearly equally divided between foreign and domestic inventors[4].

Technology Areas and Trends

Patents are classified into various technology areas, with electrical and mechanical engineering being the most prominent. The rise of information and communication technologies (ICT) has significantly influenced the increase in electrical engineering patents[4].

Patent Scope and Its Measurement

Patent scope is a key aspect of patent quality debates. Metrics such as patent maintenance payments, forward citations, and the breadth of patent classes are used to assess the scope. Narrower claims tend to have higher forward citations, indicating their impact on subsequent innovations[3].

The Alice Test: Determining Patent Eligibility

The Supreme Court's "Alice" test is crucial in determining whether patent claims are directed to abstract ideas, which are not patentable. The test involves two steps: first, determining if the claims are directed to an abstract idea, and second, assessing if the claims include elements that transform them into a patent-eligible application[2].

Example: Contour IP Holding LLC v. GoPro, Inc.

In the case of Contour IP Holding LLC v. GoPro, Inc., the court applied the Alice test to determine the patent eligibility of claims related to a point-of-view (POV) camera. The claims were found to be directed to a specific means that improves the relevant technology, thus passing the Alice test[2].

Global Dossier and Public Search Facilities

The USPTO provides several tools to facilitate patent research and management. The Global Dossier service allows users to access file histories of related applications from participating IP Offices, while the Public Search Facility in Alexandria, VA, offers public access to patent and trademark information in various formats[1].

The Need for a Small Claims Patent Court

There has been ongoing discussion about the need for a small claims patent court to address issues related to patent litigation costs and complexity. The Administrative Conference of the United States (ACUS) has conducted studies and gathered public comments on this topic, highlighting the potential benefits and challenges of such a court[5].

Patent Infringement and Litigation

Patent infringement cases, such as Contour IP Holding LLC v. GoPro, Inc., highlight the importance of clear and specific claims. These cases often involve complex legal battles over the interpretation of claim terms and the determination of patent eligibility[2].

Impact on Innovation

The clarity and scope of patent claims can significantly impact innovation. Overly broad claims can lead to increased litigation costs and diminished incentives for innovation, while well-defined claims can foster a more innovative environment by providing clear boundaries for inventors[3].

Key Takeaways

  • Clear and Specific Claims: Narrower claims are associated with higher probabilities of grant and shorter examination processes.
  • Patent Scope: Metrics such as independent claim length and count are used to measure patent breadth.
  • Technology Trends: Electrical and mechanical engineering patents dominate the USPTO's patent landscape.
  • Alice Test: A two-step test to determine if patent claims are directed to abstract ideas.
  • Global Dossier: A service providing access to file histories of related applications from participating IP Offices.
  • Small Claims Patent Court: Discussions are ongoing about the feasibility and potential structure of such a court.

FAQs

What is the purpose of the Alice test in patent law?

The Alice test is used to determine whether patent claims are directed to abstract ideas, which are not patentable. It involves two steps: first, determining if the claims are directed to an abstract idea, and second, assessing if the claims include elements that transform them into a patent-eligible application[2].

How does the Global Dossier service benefit patent stakeholders?

The Global Dossier service provides users with access to the file histories of related applications from participating IP Offices, allowing them to see the patent family for a specific application, including classification, citation data, and Office Action Indicators[1].

Why is there a discussion about a small claims patent court?

The discussion is centered around addressing the high costs and complexity associated with patent litigation. A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes[5].

What are the implications of overly broad patent claims?

Overly broad claims can lead to increased litigation costs and diminished incentives for innovation. They can also result in patents with questionable validity, which can hinder the innovation process[3].

How are patents classified by the USPTO?

The USPTO classifies patents based on technology areas, using the World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields[4].

Sources

  1. USPTO: Search for patents - USPTO.
  2. CAFC: CONTOUR IP HOLDING LLC v. GOPRO, INC.
  3. SSRN: Patent Claims and Patent Scope.
  4. NCSES: Invention: U.S. and Comparative Global Trends.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,052,161

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Polarean XENOVIEW xenon xe-129 hyperpolarized GAS;INHALATION 214375-001 Dec 23, 2022 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,052,161

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015218883 ⤷  Subscribe
Canada 2940109 ⤷  Subscribe
China 106456808 ⤷  Subscribe
European Patent Office 3107583 ⤷  Subscribe
Hungary E045999 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.